SG Americas Securities
OPTR

SG Americas Securities’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

SG Americas Securities’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-11,128
Closed -$140K – 3410
2013
Q3 		$140K Sell
11,128
-174,636
-94% -$2.31M ﹤0.01% 2441
2013
Q2 		$2.69M Buy
+185,764
New +$2.71M 0.01% 747

SG Americas Securities's OPTR Position: Q4 2013 in Review

SG Americas Securities sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 11,128 shares — an estimated $140K sold.

SG Americas Securities first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $2.69M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • SG Americas Securities reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • SG Americas Securities sold 11,128 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $140K.
  • SG Americas Securities first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • SG Americas Securities's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $2.69M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on SG Americas Securities's 13F filing for Q4 2013, filed 12 Feb 2014.